Lavipharm SA · ATHEX:LAVI
Lavipharm SA — Investor Presentation (2014)
25 slides from Lavipharm SA's investor presentation, 2014

Slide 1: Corporate Presentation
Corporate Presentation 060 CG Lavipharm

Slide 2: Who we are
Who we are A fully integrated pharmaceutical group in Greece with a 100-year history We develop, manufacture, import, market, distribute and export pharmaceutical, OTC and dermocosmetic products Partner of choice for major international pharmaceutical and consumer health companies in Greece an

Slide 3: Historical Highlights
Historical Highlights 1911 Establishment of Lavipharm 1914 Launch of Digitaline, an innovative cardiovascular product, in Greece 1958 Launch of Nitroglycerin Controlled Release tablets 1976 Dr. A. Lavidas with new management team 1977 Collaboration with L’Oreal - first to sell cosmetics through phar

Slide 4: Historical Highlights
Historical Highlights 1996 Acquisition of U.S. based R&D unit specialised in TDDS (now Lavipharm Laboratories Inc) 1997 Launch of patented acne epidermal patch worldwide by L’Oreal 2000 Acquisition of 30% of Phasex (U.S.A.) specialized in SCF 2006 FDA approval of Lavipharm's fentanyl transdermal sys

Slide 5: Operation Centers
Operation Centers Greece France Italy Headquarters Rx Rx Production / Distribution Dermocosmetics Commercial activity Food Supplements Pharma (Rx & OTC), Dermocosmetics U.S.A. NJ: Commercial Activity Pharma US & Canada R&D Pharma/ OTC

Slide 6: Lavipharm S.A.
Lavipharm S.A. Headquarters: Peania, Attica Turnover 2013 : € ~30 million Listed on the Athens Exchange since 1995 (ASE : ΛΑΒΙ)

Slide 7: Core Activities
Core Activities I. Research & Development II. Manufacturing III. Pharmaceuticals IV. Consumer Health / OTC V. Dermocosmetics VI. Wholesaling - Logistics VII. Pharmacy Services

Slide 8: I. Research & Development
I. Research & Development Greece Headquarters, Lavipharm SA Natural Products Commercial / Industrial Production USA New Jersey- Lavipharm Laboratories Drug Delivery Technologies Clinical Manufacturing

Slide 9: I. Research & Development: Pharma
I. Research & Development Drug Pre-Formulation Dosage Formulation Discovery Development Development Pharma Lavipharm Field of Activity Formulation/ Drug Delivery Molecule Particle Design Devices Design • Organic • Physical • Pharmaceutics Chemistry Chemistry • Physical Chemistry • Biotechnology • Ph

Slide 10: I. Research & Development: Pharma
I. Research & Development Transdermal (TDDS) Pharma Intra – oral (IODS) Osmotic (OODS) Protective Backing Removable layer Drug in adhesive matrix

Slide 11: Cosmetic Technologies
I. Research & Development Cosmetic Technologies

Slide 12: II. Manufacturing
II. Manufacturing PHARMACEUTICALS Tablets 830 million tabs Capsules 47 million caps TTDS 140 million pouches Liquid 23 million bottles Creams & Ointment 8 million tubes COSMETICS / OTC Creams & Emulsions 4.5 million tubes Shampoos & Lotions 6 million bottles

Slide 13: III. Pharmaceuticals
III. Pharmaceuticals Therapeutic Categories: a) Cardiology b) Chronic Pain & Oncology c) CNS d) Dermatology e) General Medicine & Respiratory f) Urology

Slide 14: III. Pharmaceuticals: Lavipharm's Pharmaceutical Products
III. Pharmaceuticals Lavipharm’ s Pharmaceutical Products Chronic Pain & Cardiology: General Medicine, CNS & Respiratory: Oncology: Nitrong TTS® Caprilon® Mundisal Gel® Fentadur® Nitrong® 2,6mg Memodrin® Terbigram® Prostaplant ® Nitrolingual Pricital® Lanex ® Kerlone®

Slide 15: III. Pharmaceuticals: Greece Main cooperations
III. Pharmaceuticals Greece Main cooperations

Slide 16: III. Pharmaceuticals: Global Market
III. Pharmaceuticals Global Market NITROGLYCERIN TRANSDERMAL (launched in EU/Canada) FENTANYL TRANSDERMAL (launched in most countries of the EU) OTHER TRANSDERMALS (under development) THIN FILM OTC products (under development)

Slide 17: III. Pharmaceuticals: Global Market Main Distributors
III. Pharmaceuticals Global Market Main Distributors

Slide 18: International presence
International presence * be >’ lel 640 CG Lavipharm

Slide 19: IV. Consumer Health / OTC
IV. Consumer Health / OTC Main Products: BETADINE (antiseptic) LAVISEPT (instant antiseptic) ALGON (pain reliever) IVALITEN, LAVITEN (anti-lice) LACTAL (gyn) TILMAN (supplements/cough & cold remedies)

Slide 20: IV. Consumer Health/OTC: Main Cooperations
IV. Consumer Health/OTC Greece Main Cooperations

Slide 21: V. Dermocosmetics
V. Dermocosmetics Brand philosophy “20 year expertise in skin biology” Promoted to Dermatologists Clinically proven efficacy Sold exclusively in pharmacies in 16 countries globally MORE THAN 20 YEARS OF KNOWLEDGE IN THE BIOLOGY OF THE SKIN

Slide 22: VI. Wholesaling – Logistics
VI. Wholesaling – Logistics Logistics services to pharmacies, hospitals and wholesalers Fully automated warehouse (600 orders per hour)

Slide 23: VII. Pharmacy Services
VII. Pharmacy Services We provide our customers (pharmacies) with: Fully integrated supply chain center Integrated I.T. system Agreements with health care products' suppliers Up-to-date product data base with continuous back up Educational / Training programs Marketing activities Pione

Slide 24

Slide 25: Visit us @ www.lavipharm.com
Visit us @ www.lavipharm.com
Source: Internet Archive copy of lavipharm.com

